Introduction
The tumor suppressor p53 is the central player in a network protecting higher eucaryotic cells against various damage that might lead to genetic alterations. p53 becomes activated through a variety of endogenous and exogenous stress signals, and mediates the ensuing cellular responses. The major p53 responses are induction of growth arrest in the G 1 and/or G 2 phases of the cell cycle, and the induction of apoptosis (May and May, 1999; Vogelstein et al., 2000) . So far, little is known about the cellular or environmental parameters that influence the decision between these responses. However, cell type and severity of the damage play a major role (Amundson et al., 1998; Sionov and Haupt, 1999) . Another question concerns the role of p53 itself in mediating the decision between growth arrest and apoptosis. Although there is evidence for a 'smart' p53 that directs the decision, most experimental data support the idea that additional cellular factors determine the outcome of the p53 response ('dumb' p53; Vousden, 2000) . Regardless of how this decision is regulated, elimination of DNA-damaged cells by p53-dependent apoptosis clearly is the preferential response with regard to tumor prevention. Tumor prevention by induction of growth arrest is not safe, as there are multiple ways to overcome such a growth arrest by additional genetic alterations, which then can lead to tumor cell outgrowth and progression.
Given the pivotal role of p53 in maintaining genomic integrity, functional inactivation of p53, or at least part of the p53 network, is an important requirement for tumor formation and progression. Consequently, p53 becomes inactivated by mutations in the p53 gene in approximately 50% of all human tumors (Hollstein et al., 1991) . However, in contrast to most carcinomas, the frequency of mutational inactivation of p53 is relatively low in hematopoetic tumors, with only about 10% of all lymphoid tumors displaying mutations in the p53 gene (Hollstein et al., 1991; Drexler et al., 2000) .
So far, the reasons for the low frequency of p53 mutations in lymphoid tumors are not understood. Three major, not mutually exclusive alternatives must be considered. First, inactivation of the p53 network by mutations in the p53 gene might not be required because of the selective functional inactivation of afferent or efferent p53 pathways during tumor development. Second, lymphoid cells might be able to counteract, under certain conditions, p53-induced apoptotic signals and consequently allow the survival of precancerous cells. Third, the response to the activation of p53 is switched from the apoptosis pathway to the growth arrest pathway, which again permits the survival of precancerous cells.
We approached this problem using an experimental system with an intact p53 network in which induction of apoptosis upon genotoxic stress is strictly p53-dependent, and in which a switch from a p53-dependent apoptosis to growth arrest can be experimentally induced. Furthermore, external antiapoptotic signals, which are especially important for the in situ survival of hematopoetic cells, should be provided in the experimental system. Such a system is provided by isolated murine splenocytes and analysis of their response to girradiation in vitro. Splenocytes consist of a mixture of about 80% (resting) B-and T-lymphocytes, the remainder mostly consisting of macrophages and granulocytes. The advantage of this system is that it resembles a primary organ culture, for example, with regard to factor secretion. Additionally, cell proliferation can be induced by external stimulation. Moreover, it has been shown that g-irradiation induced apoptosis in thymocytes, which are within the same cell lineage, is strictly p53-dependent (Lowe et al., 1993) . Last but not least, analysis of murine cells allows one to unequivocally analyse the postulated role of certain genes using the corresponding knockout mice.
Here we show that stimulation of splenocytes by ConA or PMA/ionomycin results in a switch from p53-dependent apoptosis to a p53-dependent growth arrest upon g-irradiation. The switch apparently does not result from selective transactivation of p53 target genes in the stimulated, irradiated cells, but rather from internal survival signals activated upon stimulation. Our results provide evidence that proliferative signaling in lymphocytes is linked to the activation of internal survival pathways, which are able to block the p53 apoptotic pathway in irradiated primary cells. The finding that under certain physiological conditions the p53 apoptotic pathway in lymphocytes is intercepted provides hints about mechanisms that bypass the need to mutate p53 in hematopoetic tumor cells.
Results

Irradiation-induced apoptosis in splenocytes is dependent on p53
Murine thymocytes readily undergo apoptosis upon girradiation in a strictly p53-dependent manner (Lowe et al., 1993) . We similarly analysed freshly prepared murine splenocytes. As expected, treatment with 8 Gy induced a fast apoptotic response. Already 10 h after irradiation, the majority of the genomic DNA was degraded into oligonucleosomal fragments, resulting in a typical ladder-like pattern (Figure 1a ). The amount of DNA fragmentation increased with time. Virtually no intact genomic DNA could be detected 30 h after irradiation, whereas the genomic DNA in nonirradiated control cells was not fragmented. Some background apoptosis was observed, which probably was due to the prolonged cultivation of the primary cells in vitro. In order to quantify apoptosis, the cells were subjected to flow cytometric analysis. DNA profiles 10 h after irradiation showed a G 0 /G 1 peak and a sub-G 1 population representing the apoptotic cells (Figure 1b) . Quantitative evaluation over time revealed a significant fraction of apoptotic cells already 4 h after irradiation, which increased to 60% at 10 h after treatment, and to 90% at 30 h after treatment. Background apoptosis was below 20% after 10 h, and rose to about 40% after 30 h (Figure 1c) .
No significant irradiation-induced apoptosis was observed in splenocytes derived from the corresponding p53 knockout mice (Figure 1 ), as irradiated p53 À/À cells, like nonirradiated wild-type and p53
À/À cells, only showed background apoptosis (Figure 1 ). Taken together, the results show that in nonstimulated splenocytes irradiation-induced apoptosis depends on p53.
Mitogenic stimulation of splenocytes blocks p53-induced apoptosis
We next investigated the effect of mitogenic stimulation on the survival of irradiated cells. Splenocytes were mitogenically stimulated by phorbol 12-myristate 13-acetate (PMA)/ionomycin, which is known to activate both, T and B cells (Truneh et al., 1985; Klaus et al., 1986; Li et al., 1989) . Alternatively, cells were stimulated with concanavalin A (ConA), a lectin that primarily activates T cells (Novogrodsky and Katchalski, 1971; Oppenheim and Rosenstreich, 1976) . As demonstrated by flow cytometry, apoptosis was blocked (PMA/ ionomycin-treated cells) or reduced (Con A-treated cells) if lymphocytes were mitogenically stimulated shortly before irradiation (Figure 2 ). Since at least in PMA/ionomycin-treated cells radiation-induced apoptosis could not be observed even over a prolonged period of time (30 h), we conclude that stimulation indeed blocked apoptosis and did not just delay it. Interestingly, stimulation also almost quantitatively blocked spontaneous apoptosis of nonirradiated cells.
In contrast to stimulation with PMA/ionomycin, which resulted in a complete inhibition of apoptosis, ConA treatment seemingly had only a partial effect. To prove that this difference was only apparent, and was due to the action of ConA towards a fraction of the lymphocytes, that is, T cells, we analysed the behavior of the different lymphocyte populations. We developed an immunophenotyping-apoptosis assay to examine separately the response of B and T cells to stimulation and irradiation. The assay was based on cell surface marker and on TUNEL staining, and allowed us to determine the fraction of apoptotic cells within the two major splenocyte populations by flow cytometry. Cells were analysed 10 h after irradiation, as this time point most significantly reflects the effect of radiation on p53-mediated apoptosis in splenocytes (Figures 1 and 2) . The splenocyte culture typically contained about 50% B cells and 34% T cells (Figure 3 ). The level of background apoptosis after 10 h of culture was about 15% in all cells (Figure 3a) . The percentage of apoptotic cells upon irradiation increased above 70% (Figure 3b ), which is slightly higher than the data shown in Figure 2 , probably reflecting the higher sensitivity of the TUNEL assay. With regard to ConA stimulation, the assay revealed the differential stimulatory effect on T and B cells. In agreement with the selective stimulation of T cells by ConA, the rescue effect on irradiated T cells was nearly 100% (compare the right panels of Figure 3a and c), whereas B cells were only partially protected by and Parker, 1976; Dosch et al., 1980; Hawrylowicz and Klaus, 1984) . Therefore, the observed partial overall rescue of ConA-stimulated splenocytes upon irradiation ( Figure 2 ) is based on the selectivity of ConA towards T cells, which only represent one-third of all cells. In agreement with the data shown in Figure 2 , treatment with PMA/ionomycin had a strong protective effect on both irradiated T and B cells (Figure 3d ). The fraction of apoptotic cells was comparable to that of nontreated and of PMA/ionomycin-treated control cells (Figure 3a , and data not shown). In summary, these results demonstrate that mitogenic stimulation fully protects lymphocytes against rapid, p53-induced apoptosis. Since a complete block of apoptosis in T cells can be achieved by ConA treatment in T and B cells by PMA/ionomycin treatment, both stimuli led to the same effect at the level of a single responsive cell.
Upon irradiation p53 is upregulated in both stimulated and nonstimulated cells
The lack of apoptosis in stimulated, irradiated cells could either be an upstream effect, that is, lack of signaling to p53, or a downstream effect, that is, an altered p53 response. Therefore, we asked if irradiation activated p53 in resting and in stimulated cells. A hallmark of p53 activation is the increase of p53 protein levels by post-transcriptional regulation (Kastan et al., 1991) . Disruption of the interaction with Mdm2, which targets p53 for degradation, results in the increase of the half-life of p53 (Haupt et al., 1997; Kubbutat et al., 1997) . In lymphocytes, the translational regulation of p53 expression plays an additional role (Mosner et al., 1995) . Analysis of p53 levels by Western blotting showed that p53 can be detected 4 h after irradiation in nonstimulated and stimulated lymphocytes (Figure 4a ). Thus, p53 accumulates under both conditions with the same kinetics to comparable amounts. In addition, p53 was only induced after irradiation (Figure 4a , compare lanes 5 and 6), and the increase was not the result of prolonged in vitro cultivation. The finding that the overall stabilization of p53 was similar in stimulated and nonstimulated lymphocytes upon irradiation indicates that the block of apoptosis occurs downstream of p53 in stimulated, irradiated lymphocytes.
p53 blocks entry into S phase in mitogenically stimulated and irradiated cells Stabilization of p53 in stimulated lymphocytes implies that signaling to p53 was intact. As those cells did not enter apoptosis upon irradiation, we asked whether p53 might induce a growth arrest in G 1 as an alternative response. In stimulated lymphocytes, this would result in a block of entry into S phase. Lymphocytes were pulse-labeled with [ 3 H]thymidine at different time points after stimulation to measure S phase entry. Nonirradiated cells went into S phase at 20-22 h after stimulation with either ConA or PMA/ionomycin ( Figure 4b ). In this respect, no differences could be observed in wildtype and p53
À/À cells. Upon irradiation, wild-type cells did not incorporate [ 3 H]thymidine, indicating the induction of a G 1 arrest in these lymphocytes ( Figure 4b ). The strict p53 dependence of this G 1 arrest was demonstrated by the analysis of p53 knockout cells.
Stimulated and irradiated p53
À/À cells entered the S phase to the same extent as nonirradiated cells. Lower incorporation rates at later time points most likely reflect a limited progression of replication due to double strand breaks induced by irradiation ( Figure 4b ).
Taken together, the data show that mitogenic stimulation induces a switch in the cellular response of lymphocytes to irradiation. While resting lymphocytes rapidly underwent apoptosis, activated lymphocytes were viable, but blocked in cell cycle progression.
Upon irradiation p53 transactivates target genes equally in both stimulated and nonstimulated cells
We next investigated the molecular basis of the switch in the cellular response upon genotoxic stress from resting to stimulated lymphocytes. Both responses -induction of apoptosis and induction of growth arrest -were dependent on p53. An important question therefore was whether activated p53 itself shifts the decision between cell death and cell cycle arrest by activating different sets of target genes. To resolve this question we studied by RNase protection assay (RPA) the regulation of five transcriptional targets of p53, which can be considered key targets for p53-induced pathways. Bax, Noxa and Fas play different roles in the p53-induced cell death response (Miyashita and Reed, 1995; Muller et al., 1997; , 1993) and Mdm2 is a major regulator of p53 itself (Haupt et al., 1997; Kubbutat et al., 1997) . The result of this analysis is summarized in Figure 5 , panels a-e. We found that irradiation led to a p53-dependent induction of all the genes analysed. Bax, noxa, fas and mdm2 were upregulated by a factor of two to three; p21 was induced to a much higher extent, that is, by a factor of eight. Stimulation of the cells alone induced gene expression in a p53-independent fashion, and thus independent of irradiation. In cells that were both irradiated and stimulated, both effects were superimposed, resulting in an additive activation ( Figure 5 , compare lane 4 with lanes 2 and 3).
To compare the effects of p53 on gene induction directly, we eliminated the non-p53-specific effect of growth stimulation on gene expression. The RPA results were re-evaluated by normalizing for each gene the data obtained from nonstimulated and stimulated cells to the values obtained in the corresponding nonirradiated cells. Data obtained with irradiated p53
À/À cells served as another internal control for the p53 specificity of gene activation. The resulting graph (Figure 5f ) revealed that upon irradiation, p53 equally upregulated the set of genes analysed, irrespective of whether the cells were resting (upper panel) or stimulated (lower panel). Under both conditions, p53 induced the proapoptotic genes, the p53 regulatory gene mdm2, and arrest pathway gene p21 independent of the cellular response. However, both in nonstimulated and in stimulated cells the level of p21 induction was much higher than that of the induction of the proapoptotic genes, indicating that p21 might play a special role in the p53 response to genotoxic stress. This was further suggested by the very strong increase in p21 protein levels, especially in stimulated, irradiated lymphocytes (Figure 6a ). Upregulation of p21 protein levels closely À/À cells were prepared and cultured without mitogen or with ConA. Cells were irradiated (8 Gy) or left untreated 30 min after addition of ConA or mock treatment. Cells were harvested at the indicated time points after irradiation or mock treatment. Whole cell extracts were prepared and equal amounts of total protein (100 mg) were subjected to Western blot analysis using an anti-p53 antiserum. (b) Irradiation induced a p53-dependent growth arrest in stimulated cells. Splenocytes from wild-type and p53 À/À mice were prepared and cultured with ConA or with PMA/ionomycin. Cells were irradiated (8 Gy) or left untreated 30 min after addition of the mitogens. Proliferation was measured by pulse labeling with 10 mCi [ 3 H]thymidine for 1 h at the indicated time points. Cells were harvested and the amount of incorporated radioactivity was measured by scintillation counting Modulation of p53 apoptotic signaling S Heinrichs and W Deppert Figure 5 p53 transactivates a key set of target genes to the same extent in nonstimulated and stimulated cells. Splenocytes from wildtype and p53 À/À mice were prepared and cultured with ConA or left untreated. Cells were irradiated (8 Gy) or left untreated 30 min after addition of the mitogen or mock treatment. Cells were harvested 5 h postirradiation and total RNA was prepared. The expression levels of bax, noxa, fas, mdm2 and p21 were determined by RNase Protection Assay using equal amounts of total RNA (8 mg) and quantified by Phosphor-Imager analysis (a-e). Data were normalized to nonirradiated, nonstimulated cells and represent mean values (mean7s.e.m.) from a minimum of three separate experiments. For each mRNA, one representative experiment is shown. An additional evaluation was performed by normalizing the data of nonstimulated and stimulated cells separately (f).
followed the induction of p53 protein with time. The dependence of p21 upregulation on p53 was shown using p53 knockout cells (Figure 6a, lane 7) . In contrast, the levels of p21 in irradiated nonstimulated cells were close to the limit of detection by Western blotting. The considerably lower level of p21 in resting as compared to stimulated cells, despite a similar transcriptional regulation of the p21 gene in part, reflects the different transcriptional activity in resting and in stimulated cells (see Figure 5e ), but is further enhanced by the lower level of protein synthesis in resting cells (Meyuhas, 2000) .
p21 is required to induce growth arrest, but is not necessary for the block of apoptosis p21 has been shown to be essential for the p53-induced G 1 arrest by functioning as an inhibitor of CDK/cyclin activities (El-Deiry et al., 1993; Harper et al., 1993) . In addition to its role as a mediator of the arrest pathway, an antiapoptotic activity of p21 has been described in different experimental settings (Gorospe et al., 1997; Bissonnette and Hunting, 1998; Asada et al., 1999; Tian et al., 2000; Mahyar-Roemer and Roemer, 2001) .
To test whether p21 accounted for the observed block of cell death in stimulated, irradiated cells, we compared wild-type and p21 knockout splenocytes. After stimulation and irradiation, no difference in the percentage of apoptotic cells could be observed between p21 À/À and wild-type cells (Figure 6b ). Consequently, p21 in our system did not inhibit apoptosis despite its reported antiapoptotic activity. Next, we asked whether p21 is necessary and sufficient to block entry into the S phase. Irradiated, stimulated splenocytes obtained from p21 knockout mice incorporated [ 3 H]thymidine and thus showed a lack of growth arrest (Figure 6c) . Accordingly, the p53-dependent G 1 arrest is mediated by p21. Interestingly, p21 À/À cells entered the S phase earlier than wild-type control cells, and incorporated more thymidine. This phenomenon was not seen with p53 knockout cells (see Figure 4) . The findings show that the strong induction of p21 in stimulated cells is necessary for the G 1 arrest, but not sufficient to prevent cell death.
Stimulation induces stabilization of the mitochondrial membrane potential and upregulation of Bcl-x L but not Bcl-2 So far, our results support the conclusion that the decision between growth arrest and apoptosis is not caused by differential transactivation of target genes by p53. Thus, the switch from apoptosis to growth arrest in stimulated, irradiated splenocytes could be based on an alternative mechanism. As proapoptotic signals were generated, but did not initiate cell death in stimulated, irradiated cells, we postulated that the proapoptotic signals might have been antagonized. To determine at which level the proapoptotic signals were intercepted, we first identified the cellular effector site for the induction of p53-mediated apoptosis. We focused on mitochondria, as they function as central integrators of pro-and antiapoptotic signals (Ferri and Kroemer, 2001) . Particularly, pertubation of mitochondrial integrity is involved in p53-induced apoptosis Marchetti et al., 1996; Schuler et al., 2000) . Besides the release of proapoptotic factors, for example, cytochrome c, the decrease of the mitochondrial membrane potential DC m is an indicator of cell death initiation at the mitochondrial level. Analysis of the mitochondrial membrane potential DC m in splenocytes showed that apoptotic signalling by p53 leads to a loss of DC m . In comparison to p53 À/À cells, the fraction of irradiated, nonstimulated wild-type cells with reduced DC m increased with time ( Figure 7a, upper panel) . Stimulation of the lymphocytes with ConA had a moderate overall effect on the protection of the integrity of the mitochondrial membrane, since mainly T cells À/À cells were prepared and cultured without mitogen or with ConA. Cells were irradiated (8 Gy) or left untreated 30 min after addition of ConA or mock treatment. Cells were harvested at the indicated time points after irradiation or mock treatment. Whole cell extracts were prepared and equal amounts of total protein (100 mg) were subjected to Western blot analysis using a monoclonal anti-p21 antibody. (b) Induction of p21 is not necesary for the block of apoptosis. Splenocytes from wild-type and p21
À/À cells were prepared and cultured without mitogen, with ConA or with PMA/ionomycin. Cells were irradiated (8 Gy) or left untreated 30 min after addition of the mitogen or mock treatment. Flow cytometric analysis was performed 10 h after irradiation or mock treatment as shown in Figure 1 . (c) The p53-dependent growth arrest in irradiated, stimulated cells is p21-dependent. Splenocytes from wild-type and p21 À/À mice were prepared and cultured with ConA or with PMA/ionomycin. Cells were irradiated or left untreated 30 min after addition of the mitogens. Proliferation was measured by pulse labeling with 10 mCi The mitochondrial membrane potential is strongly influenced by members of the bcl-2 gene family, with the ratio of pro-and antiapoptotic genes expressed determining the decision between membrane integrity and membrane potential breakdown (Huang and Strasser, 2000; Adams and Cory, 2001 ). As irradiation led to an increase in the expression of the proapoptotic bax gene (Figure 5 ), we asked whether the stimulation-induced block of p53-mediated apoptosis in irradiated lymphocytes might be due to the upregulated expression of antiapoptotic Bcl-2 family members, like Bcl-2 and Bclx L . Indeed, we found that stimulation led to an upregulation of Bcl-x L , starting between 4 and 6 h after stimulation (Figure 7b ), whereas the level of Bcl-2 expression remained constant even at late times after stimulation. Stimulation of lymphocytes thus leads to the selective induction of an antiapoptotic gene, which correlates with the stabilization of the mitochondrial membrane potential. The stabilization of DC m might be sufficient to counterbalance proapoptotic signals, thereby blocking the p53 apoptotic pathway like in other systems (Henry et al., 2002) . In accordance, ectopically expressed Bcl-x L was shown to antagonize apoptosis by stabilizing DC m (Vander Heiden et al., 1997).
Activation of NF-kB by stimulation correlates with induction of anti-apoptotic genes bcl-x and bfl-1
In order to characterize the signal transduction pathway leading to the upregulation of Bcl-x L , we analysed the activation of an important transcriptional activator of Bcl-x L , NF-kB. NF-kB is induced by a variety of stimuli . Besides upregulating proinflammatory factors, NF-k activation leads to the upregulation of antiapoptotic genes (Karin and Lin, 2002) . In this respect, the bcl-x promoter was characterized as an important target of NF-kB (Lee et al., 1999; Chen et al., 2000) .
To determine whether NF-kB activation might play a role in the initiation of the antiapoptotic pathway in our system, we first tested the activation of NF-kB by electrophoretic mobility shift assays (EMSA) with nuclear extracts prepared shortly after stimulation of splenocytes with PMA/ionomycin, using an NF-kB binding site-specific oligonucleotide. After stimulation, a strong increase in NF-kB binding activity was observed (Figure 8a ). The specificity of the observed band shift was confirmed by using an antibody directed Mitogenic stimulation leads to upregulation of Bcl-x L , but not Bcl-2. Splenocytes were prepared and cultured without mitogen, with ConA or with PMA/ionomycin. Cells were irradiated (8 Gy) or mock treated 30 min after addition of the mitogens. Cells were harvested at the indicated time points after irradiation or mock treatment. Whole cell extracts were prepared and equal amounts of total protein (100 mg) were subjected to Western blot analysis using a polyclonal anti-Bcl-x L antibody and a monoclonal anti-Bcl-2 antibody, respectively " Modulation of p53 apoptotic signaling S Heinrichs and W Deppert Corresponding to NF-kB activation, bcl-x L RNA levels began to rise (Figure 8b ). To further strengthen the correlation to NF-kB activation, we additionally analysed bfl-1 expression, as bfl-1 is another important NFkB target gene with antiapoptotic activity (Grumont et al., 1999; Lee et al., 1999; Zong et al., 1999) . As with bcl-x L , bfl-1 RNA levels also increased after stimulation.
In accordance with our protein expression data (Figure 7b ), the RNA levels of bcl-2 did not change under these conditions (Figure 8b ). In summary, the NF-kB pathway represents a molecular link between mitogenic stimulation and induction of antiapoptotic genes, like bcl-x L and bfl-1.
Activation of NF-kB results from the activation of protein kinase C (PKC)
It has long been recognized that PMA/ionomycin acts as an activator of NF-kB, although the mechanisms underlying this process became more apparent only in recent years. Several studies have shown that signal transduction mediated by the T-and the B-cell receptors, and its mimicry by treatment of the PMA/ ionomycin cells, involves PKC as mediator of NF-kB activation (Coudronniere et al., 2000; Lin et al., 2000; Sun et al., 2000; Krappmann et al., 2001) . To test for an involvement of PKC in NF-kB activation and the subsequent induction of antiapoptotic target genes, we used the broad-range PKC inhibitor GF109203X. Inhibition of PKC abrogated the activation of NF-kB as measured by EMSA (Figure 8a ), and also strongly reduced the induction of the NF-kB target genes bcl-x L and bfl-1 (Figure 8b ). To determine whether blocking the PKC pathway restores the apoptotic pathway in stimulated irradiated cells, we evaluated the effect of GF109203X on the p53 response to irradiation of stimulated cells. As shown in Figure 8c , suppression of PKC activity at least partly abolished the antiapoptotic effect of stimulation. Importantly, GF109203X had no effect on unstimulated, irradiated cells, confirming its specificity. The data show that inhibition of p53-induced apoptosis by stimulation involving activation of the PKC pathway. A critical downstream factor of this pathway in lymphocytes is NF-kB.
Discussion
The two major cellular responses of the tumor suppressor p53 after genotoxic stress are induction of growth arrest (mostly in G 1 ), or induction of apoptosis. So far, little is known about the parameters determining this decision. In this study, we used primary mouse splenocytes as a cellular system to investigate the effect of different growth states (resting vs stimulated) towards the cellular reaction to activation of p53. Freshly prepared splenocytes mainly consist of resting B and T lymphocytes, which can be synchronously stimulated for proliferation. In addition, the system closely resembles an organ culture in terms of interdependence of the individual cell types, and is amenable to genetic analyses by using the appropriate knockout mice. We showed that resting lymphocytes underwent rapid apoptosis upon irradiation, whereas lymphocytes stimulated for proliferation were protected against cell death and went into a growth arrest (Figures 1 and 2) . p53 became activated under both conditions (Figure 4) . Importantly, induction of apoptosis and growth arrest were found to be strictly dependent on p53 (Figures 1  and 4) . As a likely interpretation for this switch in the cellular response, we analysed whether differential transactivation of p53 target genes might be responsible. Despite the different cellular response to irradiation in resting and in stimulated splenocytes, p53 transactivated the set of p53 key target genes analysed (noxa, bax, fas, mdm2 and p21) to the same extent ( Figure 5) . Although not all known proapoptotic target genes were analysed in this study, our results still support the assumption that p53 in our system is a 'dumb' p53. Upon activation, a 'dumb' p53 always induces the same set of target genes, including genes involved in growth arrest and apoptosis (Vousden, 2000) . In the case of apoptosis induction, the proapoptotic signaling is effective. If growth arrest is the outcome, the proapoptotic signals are intercepted and the concomitant growth arrest signals prevail.
Consequently, we postulated that in our system apoptosis should be inhibited by a different mechanism than selective transactivation. We provide evidence that in stimulated cells the apoptotic p53 response, which is very effective in resting lymphocytes, is blocked by the non-p53-dependent activation of survival pathways. Blocking of apoptotic signaling then resulted in a p53-dependent growth arrest that prevented the damaged cells from entering the S phase. The activation of survival pathways has already been recognized as a major determinant of the cells' fate upon p53 activation in hematopoetic tumor cells. The presence of cytokines or growth factors was able to block proapoptotic signaling induced by p53 (Yonish-Rouach et al., 1991; Abrahamson et al., 1995; Canman et al., 1995; Lin and Benchimol, 1995; Lee, 1998) . Our data obtained from primary cells suggest that growth stimulation leads to activation of NF-kB, involving the PKC pathway. NFkB is a major player in the activation of antiapoptotic pathways, as exemplified in our study by activation of the NF-kB target genes bcl-x L and bfl-1 (Figure 8) . The antiapoptotic effect of Bcl-x L and Bfl-1 is based on the protection of the integrity of the mitochondrial membrane (Vander Heiden et al., 1997; Werner et al., 2002) . We thus postulate that stimulation disrupted the p53 apoptotic signaling pathway at least in part by stabilizing the mitochondrial membrane potential (Figure 7) . In accordance we found a strong correlation between the stabilization of the mitochondrial membrane potential and the upregulated expression of Bcl-x L , and possibly other antiapoptotic proteins like Bfl-1 (Figures 7 and 8) . Thus, it is most likely that growth stimulation inhibited p53-mediated cell death by antagonizing the effects of proapoptotic proteins of the Bcl-2 family like Bax, Bak, Noxa and Puma at the mitochondrial level.
Since signals from different pathways converge on the level of mitochondrial integrity, maintenance or loss of mitochondrial integrity represents an important decision-making step in integrating apoptotic signals (Ferri and Kroemer, 2001) . At this step, proapoptotic p53 signals can be efficiently blocked, for example, by overexperession of Bcl-2 or E1B 19K (Chiou et al., 1994; Han et al., 1996) . The protective effect of cytokines is mediated by activation of Stat pathways, which can result in transactivation of bcl-x L (CatlettFalcone et al., 1999; Dumon et al., 1999; Silva et al., 1999) . Inhibition of p53-dependent apoptosis by Wisp-1 also involves upregulation of Bcl-x L (Su et al., 2002) . The results in conjunction with our data show that signal integration at the mitochondrial level is a common platform that defines an important checkpoint for p53-induced apoptosis.
The observed linkage of proliferative signals to antiapoptotic signals is probably a consequence of the high proliferative potential of lymphocytes coupled with their high sensitivity towards cell death. Both pathways are extremely important for the biological function and homeostasis of these cells. Upregulation of Bcl-x L in T cells Broome et al., 1995) and in B cells (Choi et al., 1995; Grillot et al., 1996) after mitogenic stimulation ensures that a strong proliferative signal does not result in apoptosis. As shown here, these mitogenic signals are also able to block apoptosis induced by p53 after genotoxic stress, and possibly will also block apoptosis after aberrant proliferative signaling induced by oncogene activation in a precancerous cell.
In a tumor cell, abrogation of the p53 apoptosis pathway by antiapoptotic signals constitutes the loss of the most relevant downstream tumor suppressing pathway. The coupling of proliferative signaling with the effective induction of antiapoptotic signals in lymphocytes therefore might explain the comparatively weak selective pressure to inactivate p53 directly in the chain of genetic events leading to leukemia or lymphoma. In support of this hypothesis is the recent in vivo evidence that selection against the apoptotic function of p53 is sufficient for a functional loss of its tumor suppressor activity in lymphomagenesis (Schmitt et al., 2002) . The dysregulation of the mitochondrial checkpoint by overexpression of an antiapoptotic protein (like Bcl-2), or the loss of a gatekeeper protein (like Bax) decisively suppresses the need to mutate p53.
In our model, p53 still signaled growth arrest to the primary cells that was only dependent on p21. In tumor cells, a p21-induced growth arrest might be easily compensated by additional genetic alterations that eliminate the G 1 checkpoint of the cell cycle (Sherr and Roberts, 1999) . Actually, tumor cells are known to tolerate high levels of p21, which might even be advantageous for tumor progression, since several mediators of growth arrest, including p21, have been shown to exert antiapoptotic activities (Samuel et al., 2001) . Although in splenocytes the activation of p21 was not sufficient to block apoptosis (Figure 6 ), it may still support suppression of apoptosis by its antiapoptotic activities, as illustrated in other experimental systems (Chattopadhyay et al., 2001) .
In wild-type p53 expressing tumor cells not only activation of the tumor suppressor p53 during therapy is important, but also the achievement of the appropriate cellular response, namely induction of apoptosis. As apoptotic signaling might be blocked, an important finding of our study is that apoptotic signaling of p53 in stimulated, damaged cells could be at least partially restored by blocking a key mediator of the stimulation pathway, PKC, thereby demonstrating that antiapoptotic signaling can be reversed. The treatment of tumors with a wild-type p53 status thus should make use of the capacity of p53-induced proapoptotic signals to be converted into an apoptotic response. This may require a combined approach, that is, activation of p53 and blockage of antiapoptotic signaling pathways. Therefore, it will be extremely important to decipher the pathways blocking such proapoptotic signals. Elucidation of such pathways, in primary and in tumor cells, will provide information about antiapoptotic pathways that can be blocked, and should enable the development of small molecules inhibiting, for example, PKC, NFkB, or Bcl-2 and Bcl-x L . In combination with classical chemo-or radiation-therapy, such a combined approach could improve the outcome of conventional therapy in wild-type p53 expressing tumors.
Materials and methods
Antibodies
The following antibodies were used: Bcl-x (rabbit, polyclonal), Bcl-2 (clone 7), p21 (SX118), PE-conjugated CD45R/B220 (RA3-6B2) and PE-conjugated CD3e (145-2C11) were obtained from BD Biosciences. Mouse monoclonal antibody to bromodeoxyuridine conjugated to FITC (BMC 9318) was purchased from Roche. p53 was detected by using a polyclonal rabbit serum (W Deppert).
Preparation and culture of splenocytes BALB/c mice, BALB/c p53 À/À mice and FvB/n p21 À/À mice were maintained under SPF conditions. Culture media were purchased from Invitrogen/Life Technologies. Mice (8-10 weeks of age) were killed by cervical dislocation, spleens were removed and a single-cell suspension was obtained by forcing spleens through a fine mesh wire net. Red blood cells were removed by osmotic shock with NH 4 Cl (0.89%). Splenocytes were washed and resuspended in RPMI 1640 medium supplemented with fetal bovine serum (5%), l-glutamine (2 mm), 2-mercaptoethanol (50 mm), penicillin (100 U/ml) and streptomycin (100 mg/ml). Cells were cultured in a humidified atmosphere (5% CO 2 , 371C) in 25 ml T-flasks (protein and RNA preparations), flat-bottomed 24-well culture plates (apoptosis assays) or flat-bottomed 96-well culture plates (proliferation assay) at a density of 4 Â 10 6 cells/ml. Depending on the experiment, cells were left untreated or stimulated with Con A (3 mg/ml, Sigma) or PMA (10 ng/ml, Calbiochem) plus ionomycin (500 ng/ml, Calbiochem). In irradiation experiments splenocytes were exposed to a 137 Cs source for the appropriate time to reach 8 Gy. Irradiation was done 30 min after stimulation. Incubation with the inhibitor GF109203X (2 mm, Calbiochem) started 45 min before stimulation.
Apoptosis assays
DNA fragmentation Cells were harvested and lysed in 25 mm Tris/HCl (pH 8.0), 400 mm NaCl, 2 mm EDTA, 0.5% SDS and 0.2 mg/ml proteinase K for 6 h at 501C. DNA was extracted twice with phenol, once with chloroform/isoamylalcohol (24/1) and precipitated. Equal amounts of DNA (2.5 mg) were subjected to electrophoresis on a 1% agarose gel, stained with ethidium bromide and visualized by UV illumination.
DNA content by flow cytometry Cells were harvested, washed with PBS, resuspended in a small volume of PBS and fixed in ice-cold ethanol (75%). After storage for at least 3 h at -201C, cells were washed with PBS and resuspended in PBS containing RNase A (0.2 mg/ml) and propidium iodide (20 mg/ml, Sigma). Flow cytometry was performed with an EPICS XL flow cytometer and data were analysed with the Expo32 software (Coulter).
TUNEL immunophenotyping (simultaneous determination of cell type and apoptosis)
Cells (2 Â 10 6 ) were washed with PBS containing BSA (0.5%), preincubated with rat IgG (0.2 mg/ml) for 15 min and fluorochrome-coupled antibody was added (2 mg). After incubation in the dark (30 min, 41C) the cell suspension was washed three times. Subsequent to resuspension in 100 ml PBS, 1 ml of PBS containing formaldehyde (1%) was added and the suspension was incubated on ice (15 min). The cells were washed once, resuspended in 100 ml PBS and fixed with 1 ml ice-cold ethanol (80%). After storage at -201C for 3 h and two washing steps (PBS only), each sample was treated at 371C for 45 min with 40 ml reaction mix (20 U TdT, 0.1 mm BrdUTP in reaction buffer (MBI/Fermentas)). The reaction was diluted with 0.5 ml PBS (containing 0.5% BSA and 0.1% Triton) and centrifuged. Staining was carried out by incubation with 0.3 mg anti-BrdU antibody in dilution solution (20 ml) for 30 min at room temperature. For flow cytometric analysis 0.5 ml PBS was added. The detection of apoptotic cells was carried out with the 505/25 nm bandpass filter (FL1) and the 560/90 nm bandpass filter (FL2) was used to identify the immunophenotype.
Mitochondrial membrane potential
The mitochondrial membrane potential (DC m ) was determined by flow cytometry using 5,5 0 ,6,6 0 -tetrachloro-1,1 0 ,3,3 0 -tetraethylbenzimidazolylcarbocyanine iodide (JC-1, Molecular Probes). Cells (4 Â 10 6 ) were washed with PBS and incubated with JC-1 (5 mg/ml) at room temperature in the dark for 20 min. The cell suspension was washed and analysed by flow cytometry using the 488 nm line of an argon ion laser for excitation (Epics XL, Coulter). Red and green emitted fluorescence was collected through 505/25 nm (FL1) and 560/90 nm (FL2) bandpass filters and evaluated by a dot plot (Expo32 software, Coulter). Cells with a decrease in the red/green fluorescence intensity were counted.
Proliferation assay
To detect S phase entry after stimulation, cells were pulselabeled with 10 mCi [ 
RNA analysis
Total RNA was prepared using the acid guanidium thiocyanate-phenol-chloroform extraction method (Chomczynski and Sacchi, 1987) . RNase protection was conducted essentially as described elsewhere (Tymms, 1995) . DNA templates were generated by reverse transcription PCR, cloning into Bluescript KS and SK vectors (Stratagene) and digestion with an appropriate restriction enzyme to generate linear DNA.
32 Plabeled riboprobes were generated by runoff transcription, which protected the following mRNA fragments: p21 (nucleotides 316-478; Accession number U 24173), mdm2 (nucleotides 469-797; Accession number U 47934), fas (nucleotides 659-871; Accession number M83649), noxa (nucleotides 319-467; Accession number AB 041230), bax (nucleotides 230-502; Accession number L 22472), bcl-2 (nucleotides 266-463; Accession number NM 009741), bfl-1 (nucleotides 27-331; Accession number NM 009742) and bcl-x L (nucleotides 303-655; Accession number U 10101). Aliquots of total RNA (8 mg) from each sample were hybridized with the appropriate riboprobes in separate tubes. After digestion with RNase A/ T1, protected fragments were separated on 6% denaturing gels. Gels were dried and exposed to Phosphor-Imager screens. Quantification of radioactivity of protected fragments was done using Tina 2.09 software (Raytest).
Western blot
Whole cell protein extracts were obtained by cell lysis with 50 mm HEPES/KOH (pH 7.4), 150 mm NaCl, 0.5% NP-40 containing protease inhibitors (5 mg/ml each Pepstatin A, Aprotinin, Leupeptin and 125 mg/ml Prefabloc SC). Extracts were cleared by centrifugation and 100 mg aliquots of soluble proteins were loaded onto SDS-polyacrylamide gels in SDS sample buffer. After electrophoresis, proteins were transferred to PVDF membranes (Immobilon, Millipore). The membranes were blocked in Tris-buffered saline containing 0.1% Tween (TBS-T) and 5% nonfat dry milk for 1 h, then incubated with antibodies in TBS-T containing 5% nonfat dry milk for 1 h. The secondary antibodies were either peroxidase-conjugated goat anti-rabbit or goat anti-mouse Igs in TBS-T containing 5% dried milk. Expected proteins were detected by the ECL method (Amersham Pharmacia Biotech).
Analysis of NF-kB activation by EMSA
Nuclear extracts were prepared as described by Schreiber et al. (1989) . Double-stranded oligonucleotides corresponding to the NF-kB binding site of the mouse Igk enhancer (TCAACAGAGGGbGACTTTCCGAGAGGC) were annealed and endlabeled using polynucleotide kinase and [g-32 P]ATP. Nuclear extracts (5 mg) were incubated with labeled oligonucleotide (30 000 c.p.m.) in 30 ml of incubation buffer (10 mm Tris-HCl pH 7.5. 50 mm NaCl, 1 mm EDTA, 1 mm DTT, 5% glycerol, 15 ng/ml sonicated herring sperm DNA) for 30 min at room temperature. Specificity of NF-kB binding activity was confirmed by competition with excess of nonlabeled oligonucleotide or supershift with an antibody against p50 (D-17, Santa Cruz Biotechnology). DNA-protein complexes were resolved by electrophoresis in a 6% nondenaturing polyacrylamide gel and analysed by autoradiography.
Abbreviations
ConA, Concanavalin A; EMSA, electrophoretic mobility shift assay; FITC, fluorescein isothiocyanate; NF-kB, nuclear factor kB; PE, phycoerythrin; PKC, protein kinase C; PMA, phorbol 12-myristate 13-acetate; PVDF, polyvinylidene difluoride.
